Cargando…

Risk Factors of 30-Day All-Cause Mortality in Patients with Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection

An optimal antimicrobial regimen for the treatment of patients with carbapenem-resistant Klebsiella pneumoniae (CRKP) bloodstream infection (BSI) is currently unavailable. This study aimed to identify the appropriate antibiotics and the risk factors of all-cause mortality for CRKP BSI patients. This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Keh-Sen, Tong, Yao-Shen, Lee, Ming-Tsung, Lin, Hung-Yu, Lu, Min-Chi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303346/ https://www.ncbi.nlm.nih.gov/pubmed/34209780 http://dx.doi.org/10.3390/jpm11070616

Ejemplares similares

Adipose tissue is a predictor of 30-days mortality in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae
por: Ying, Piaopiao, et al.
Publicado: (2022)

Clinical and Bacterial Characteristics of Klebsiella pneumoniae Affecting 30-Day Mortality in Patients With Bloodstream Infection
por: Wu, Xingbing, et al.
Publicado: (2021)

Predictors of Occurrence and 30-Day Mortality for Co-Infection of Carbapenem-Resistant Klebsiella pneumoniae and Carbapenem-Resistant Acinetobacter baumannii
por: Lv, Dongmei, et al.
Publicado: (2022)

Outcomes and Risk Factors of Bloodstream Infections Caused by Carbapenem-Resistant and Non-Carbapenem-Resistant Klebsiella pneumoniae in China
por: Liang, Xiaoxue, et al.
Publicado: (2022)

Epidemiology and Genomic Characteristics of Bloodstream Infection Caused by Carbapenem-Resistant Klebsiella pneumoniae With Decreased Susceptibility to Aztreonam/Avibactam in China
por: Yu, Wei, et al.
Publicado: (2022)

Early use of polymyxin B reduces the mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection
por: Liang, Qiqiang, et al.
Publicado: (2019)

2277. Comparison of 30-day Crude Mortality Rates in Patients with Bloodstream Infections (BSIs) Caused by Colistin Susceptible-(ColS-CRKp) vs. Colistin and Carbapenem-Resistant Klebsiella pneumoniae(ColR-CRKp)
por: Tarik Aslan, Abdullah, et al.
Publicado: (2019)

Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections and Outcomes
por: Yuan, Youhua, et al.
Publicado: (2020)

Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae
por: Yu, Zhenwei, et al.
Publicado: (2022)

Risk Factors for Mortality and Outcomes in Hematological Malignancy Patients with Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
por: Meng, Haiyang, et al.
Publicado: (2022)

Clinical and Molecular Characterizations of Carbapenem-Resistant Klebsiella pneumoniae Causing Bloodstream Infection in a Chinese Hospital
por: Zhang, Na, et al.
Publicado: (2022)

Epidemiology of Klebsiella pneumoniae bloodstream infections in a teaching hospital: factors related to the carbapenem resistance and patient mortality
por: Tian, Lijun, et al.
Publicado: (2016)

No Carbapenem Resistance in Pneumonia Caused by Klebsiella Species
por: Yayan, Josef, et al.
Publicado: (2015)

Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective study
por: Sun, Xiangyuan, et al.
Publicado: (2023)

Antibacterial Activity and Optimal Treatment of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Bloodstream Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae
por: Yu, Wei, et al.
Publicado: (2021)

Risk Factors for Carbapenem-resistant Klebsiella pneumoniae Infection and Mortality of Klebsiella pneumoniae Infection
por: Wang, Zhe, et al.
Publicado: (2018)

Preliminary exploration on the serum biomarkers of bloodstream infection with carbapenem‐resistant Klebsiella pneumoniae based on mass spectrometry
por: Bao, Jinfeng, et al.
Publicado: (2021)

Mortality markers in nosocomial Klebsiella pneumoniae bloodstream infection
por: Durdu, Bulent, et al.
Publicado: (2016)

A retrospective, comparative analysis of risk factors and outcomes in carbapenem-susceptible and carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infections: tigecycline significantly increases the mortality
por: Xiao, Tingting, et al.
Publicado: (2018)

Clinical Features and Risk Factors Associated With 30-Day Mortality in Patients With Pneumonia Caused by Hypervirulent Klebsiella pneumoniae (hvKP)
por: Hwang, Jeong-Hwan, et al.
Publicado: (2020)

The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients
por: Maraolo, Alberto E., et al.
Publicado: (2021)

Risk factors and mortality for elderly patients with bloodstream infection of carbapenem resistance Klebsiella pneumoniae: a 10-year longitudinal study
por: Chen, Yili, et al.
Publicado: (2022)

Epidemiology and mortality outcome of carbapenem- and colistin-resistant Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa bloodstream infections
por: Balkhair, A., et al.
Publicado: (2023)

Distribution of fluoroquinolone resistance determinants in Carbapenem-resistant Klebsiella pneumoniae clinical isolates associated with bloodstream infections in China
por: Zhan, Qing, et al.
Publicado: (2021)

Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China
por: Li, Yuanyuan, et al.
Publicado: (2020)

Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae: results from a multicentre retrospective study
por: Oliva, A, et al.
Publicado: (2022)

A67 Bloodstream infections by carbapenem-resistant Klebsiella pneumoniae subsp. pneumoniae: Bayesian phylogenetic analysis of whole genomes
por: Cella, Eleonora, et al.
Publicado: (2019)

Molecular characterization of carbapenem-resistant and virulent plasmids in Klebsiella pneumoniae from patients with bloodstream infections in China
por: Yang, Yongqiang, et al.
Publicado: (2021)

A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
por: Luterbach, Courtney L., et al.
Publicado: (2022)

Appropriate Treatment for Bloodstream Infections Due to Carbapenem-Resistant Klebsiella pneumoniae and Escherichia coli: A Nationwide Multicenter Study in Taiwan
por: Lin, Yi-Tsung, et al.
Publicado: (2018)

Erratum for Zhang et al., “Clinical and Molecular Characterizations of Carbapenem-Resistant Klebsiella pneumoniae Causing Bloodstream Infection in a Chinese Hospital”
por: Zhang, Na, et al.
Publicado: (2022)

Effect of N-Acetylcysteine Administration on 30-Day Mortality in Critically Ill Patients with Septic Shock Caused by Carbapenem-Resistant Klebsiella pneumoniae and Acinetobacter baumannii: A Retrospective Case-Control Study
por: Oliva, Alessandra, et al.
Publicado: (2021)

Prediction of 30-Day Mortality Using the Quick Pitt Bacteremia Score in Hospitalized Patients with Klebsiella pneumoniae Infection
por: Su, Ching, et al.
Publicado: (2023)

Epidemiology of bloodstream infections sustained by carbapenem-resistant Klebsiella pneumonia in a large teaching hospital in northern Italy
por: Alicino, C, et al.
Publicado: (2015)

Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant Klebsiella pneumoniae in Patients with Hematologic Malignancies
por: Zhang, Piaopiao, et al.
Publicado: (2020)

Derivation of a Model to Guide Empiric Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection in an Endemic Area
por: Weston, Gregory, et al.
Publicado: (2020)

Cost-effectiveness analysis of ceftazidime-avibactam as definitive treatment for treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infection
por: Kong, Wenqiang, et al.
Publicado: (2023)

Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study
por: Chen, Jie, et al.
Publicado: (2022)

Genomic epidemiology study of Klebsiella pneumoniae causing bloodstream infections in China
por: Jia, Xinmiao, et al.
Publicado: (2021)

Transporter Genes and fosA Associated With Fosfomycin Resistance in Carbapenem-Resistant Klebsiella pneumoniae
por: Wang, Yu-Ping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cn10fbi8695j02bv2th89latm6